Boothbay Fund Management’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.3K Hold
27,126
– – ﹤0.01% 1862
2026
Q2
$36.3K Hold
27,126
– – ﹤0.01% 2125
2026
Q1
$33.6K Hold
27,126
– – ﹤0.01% 1943
2025
Q4
$33.9K Sell
27,126
-174,372
-87% -$234K ﹤0.01% 1848
2025
Q3
$282K Buy
+201,498
New +$279K ﹤0.01% 1480

Other funds holding PMVP

Boothbay Fund Management's PMVP Position: Q3 2026 in Review

Boothbay Fund Management held its PMV Pharmaceuticals (PMVP) position steady in Q3 2026 at 27,126 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Boothbay Fund Management first reported a position in PMVP in Q3 2025 and has held it in 5 quarters since. The position peaked at $282K in Q3 2025. 65 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.

  • Boothbay Fund Management held 27,126 shares of PMV Pharmaceuticals worth $45.3K as of Q3 2026.
  • Boothbay Fund Management left its PMV Pharmaceuticals share count unchanged in Q3 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1862 holding.
  • Boothbay Fund Management first reported a position in PMV Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Boothbay Fund Management's PMV Pharmaceuticals position peaked at $282K in Q3 2025.
  • 65 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.